Clinical Trials
4 trialsNCT03940131 2022-04-06
REPAN
King Abdullah Medical City
Phase 2 Unknown
NCT03939962 2022-01-26
Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma
Henan Cancer Hospital
Phase 2 Unknown
NCT02845908 2021-04-23
POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC
Fujian Cancer Hospital
Phase 2 Completed
NCT04155671 2019-11-07
POF Versus FOLFOX Plus IP Paclitaxel in AGC
Fujian Cancer Hospital
Phase 2 Unknown